Results 341 to 350 of about 177,501 (382)

Clinical evaluation and outcome in heart failure patients receiving chemotherapy with different anti‐cancer agents

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 1965-1976, June 2025.
Abstract Background The optimal strategy for modern chemotherapy should be based on a comprehensive approach for cancer patients with cardiovascular diseases. Therefore, cardio‐oncology has received increasing attention owing to the cardiotoxic effects of anti‐cancer therapies.
Tomiko Sunaga   +7 more
wiley   +1 more source

Treatment of pediatric severe acute myopericarditis with anakinra: a case report and literature review. [PDF]

open access: yesFront Pediatr
Licciardi F   +5 more
europepmc   +1 more source

Cardiac myosin binding protein C correlate with cardiac troponin I during an exercise training program in patients with HFrEF

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 2382-2386, June 2025.
Abstract Background Cardiac myosin binding protein C (cMyC) is an emerging new biomarker of myocardial injury rising earlier and cleared faster than cardiac troponins. It has discriminatory power similar to high‐sensitive troponins in diagnosing myocardial infarction in patients presenting with chest pain. It is also associated with outcome in patients
E. Riveland   +12 more
wiley   +1 more source

Acute Kidney Injury and Viral Myocarditis Secondary to Acute Epstein-Barr Virus Infection. [PDF]

open access: yesCureus
Santos Reis C   +5 more
europepmc   +1 more source

Immune checkpoint inhibitors and myocarditis in advanced non-small cell lung cancer: a nationwide cohort study. [PDF]

open access: yesCardiooncology
Li FX   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy